Dara BioSciences said today it granted exclusive worldwide rights to develop and commercialize its DB959 to T3D Therapeutics, which will reposition the experimental drug to fight Alzheimer’s disease.
RESEARCH TRIANGLE PARK — In a landscape littered with disappointment in the battle against the global scourge of Alzheimer’s disease, an RTP-based company is offering a new chance for hope. T3D ...
Alzheimer's disease expert Dr. Robert Alexander will help shape the future development path of T3D Therapeutics' lead drug candidate T3D-959 as a potential disease remedial therapy for Alzheimer's ...
Are researchers close to redefining how Alzheimer's disease causes brain cells to fail?A new drug known as T3D-959 treats the disease as though it's actually "diabetes of the brain" -- and many ...
MORRISVILLE — T3D Therapeutics of Research Triangle Park has enlisted an all-star team of Alzheimer’s disease experts to guide the science behind its potential drugs for treating the affliction. The ...
RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / April 20, 2021 / T3D Therapeutics, Inc. ("T3D"), a clinical stage drug development company engaged in the development of T3D-959, a new orally administered ...
T3D Therapeutics sued Clinilabs, CCM Clinical Research Group and other defendants on July 25 in Florida Circuit Court for Miami-Dade County for alleged fraud, claiming hundreds of millions of dollars ...
The boxing glove is one of those timeless fitness silhouettes, one that’s remained relatively unchanged throughout history. Sure, advancements in materials have helped improved safety, performance and ...
What if we told you that you could be holding in your hand a key piece to your next 3D printer? If Taiwan-based 3D-printing startup T3D has anything to do with it, your smartphone will have you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback